A role of Heat Shock Protein 70 in Photoreceptor Cell Death: Potential as a Novel Therapeutic Target in Retinal Degeneration.

Abstract:

:Retinal degenerative diseases (RDs) such as retinitis pigmentosa (RP) are a genetically heterogeneous group of disorders characterized by night blindness and peripheral vision loss, which caused by the dysfunction and death of photoreceptor cells. Although many causative gene mutations have been reported, the final common end stage is photoreceptor cell death. Unfortunately, no effective treatments or therapeutic agents have been discovered. Heat shock protein 70 (HSP70) is highly conserved and has antiapoptotic activities. A few reports have shown that HSP70 plays a role in RDs. Thus, we focused on the role of HSP70 in photoreceptor cell death. Using the N-methyl-N-nitrosourea (MNU)-induced photoreceptor cell death model in mice, we could examine two stages of the novel cell death mechanism; the early stage, including HSP70 cleavage through protein carbonylation by production of reactive oxygen species, lipid peroxidation and Ca(2+) influx/calpain activation, and the late stage of cathepsin and/or caspase activation. The upregulation of intact HSP70 expression by its inducer is likely to protect photoreceptor cells. In this review, we focus on the role of HSP70 and the novel cell death signaling process in RDs. We also describe candidate therapeutic agents for RDs.

journal_name

CNS Neurosci Ther

authors

Furukawa A,Koriyama Y

doi

10.1111/cns.12471

subject

Has Abstract

pub_date

2016-01-01 00:00:00

pages

7-14

issue

1

eissn

1755-5930

issn

1755-5949

journal_volume

22

pub_type

杂志文章,评审
  • A novel, nonbinary evaluation of success and failure reveals bupropion efficacy versus methamphetamine dependence: reanalysis of a multisite trial.

    abstract::A multisite, double-blind, placebo-controlled trial of bupropion for methamphetamine dependence was reanalyzed using a novel, nonbinary method of evaluating success and failure. The original analysis focused on a group response endpoint (the change in percentage of participants with methamphetamine-free urines each we...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1111/j.1755-5949.2011.00263.x

    authors: McCann DJ,Li SH

    更新日期:2012-05-01 00:00:00

  • Candesartan ameliorates brain inflammation associated with Alzheimer's disease.

    abstract:AIMS:Alzheimer's disease (AD) pathology is associated with brain inflammation involving microglia and astrocytes. The renin-angiotensin system contributes to brain inflammation associated with AD pathology. This study aimed to investigate the role of candesartan, an angiotensin II type 1 receptor blocker, in modulation...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.12802

    authors: Torika N,Asraf K,Apte RN,Fleisher-Berkovich S

    更新日期:2018-03-01 00:00:00

  • Histone deacetylases and mood disorders: epigenetic programming in gene-environment interactions.

    abstract::Epigenetics involves molecular mechanisms related to gene expression independent of DNA sequence, mostly mediated by modification of chromatin histones. It has recently been suggested that these transcriptional changes may be implicated in the pathophysiology of mood disorders. In addition, histone deacetylase (HDAC) ...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1755-5949.2010.00203.x

    authors: Machado-Vieira R,Ibrahim L,Zarate CA Jr

    更新日期:2011-12-01 00:00:00

  • Calcitonin gene-related peptide (CGRP): A novel target for Alzheimer's disease.

    abstract::Alzheimer's disease (AD) is leading cause of death among older characterized by neurofibrillary tangles, oxidative stress, progressive neuronal deficits, and increased levels of amyloid-β (Aβ) peptides. Cholinergic treatment could be the best suitable physiological therapy for AD. Calcitonin gene-related peptide (CGRP...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/cns.12696

    authors: Singh Y,Gupta G,Shrivastava B,Dahiya R,Tiwari J,Ashwathanarayana M,Sharma RK,Agrawal M,Mishra A,Dua K

    更新日期:2017-06-01 00:00:00

  • Gender-linked stem cell alterations in stroke and postpartum depression.

    abstract::Stroke is a significant unmet clinical need. The current stroke treatment of tissue plasminogen activator is limited to the very acute 4.5 h after disease onset which benefits only less than 3% of ischemic stroke patients. Our overarching hypothesis advances the notion that gender, which has been established as a como...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/cns.12339

    authors: Pabón MM,Ji XM,Fernandez JW,Borlongan CV

    更新日期:2015-04-01 00:00:00

  • Do stroke patients have an increased risk of developing suicidal ideation or dying by suicide? An overview of the current literature.

    abstract::Stroke is a leading cause of death that affects 15 million people worldwide each year. Increasing evidence suggests that stroke confers substantial risk for suicide and following a stroke, patients frequently develop poststroke depression, which is a well-established risk factor for suicide. In this overview of the cu...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1755-5949.2012.00364.x

    authors: Pompili M,Venturini P,Campi S,Seretti ME,Montebovi F,Lamis DA,Serafini G,Amore M,Girardi P

    更新日期:2012-09-01 00:00:00

  • Pathological changes in neurovascular units: Lessons from cases of vascular dementia.

    abstract::Vascular dementia (VD) is the second leading cause of dementia after Alzheimer's disease (AD). The decrease of cerebral blood flow (CBF) to different degrees is one of the main causes of VD. Neurovascular unit (NVU) is a vessel-centered concept, emphasizing all the cellular components play an integrated role in mainta...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.13572

    authors: Li C,Wang Y,Yan XL,Guo ZN,Yang Y

    更新日期:2021-01-10 00:00:00

  • Variants of genes encoding TNF receptors and ligands and proteins regulating TNF activation in familial multiple sclerosis.

    abstract:INTRODUCTION:Numerous genetic variants have been associated with susceptibility to multiple sclerosis (MS). Variants located in genes involved in specific pathways, such as those affecting TNF-α, can contribute to the risk of MS. The purpose of this study was to determine whether variants of these genes are associated ...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.13456

    authors: Torre-Fuentes L,Matías-Guiu JA,Pytel V,Montero-Escribano P,Maietta P,Álvarez S,Gómez-Pinedo U,Matías-Guiu J

    更新日期:2020-11-01 00:00:00

  • Disease-modifying effects of RHC80267 and JZL184 in a pilocarpine mouse model of temporal lobe epilepsy.

    abstract:INTRODUCTION:Patients with temporal lobe epilepsy (TLE) often suffer from comorbid psychiatric diagnoses such as depression, anxiety, or impaired cognitive performance. Endocannabinoid (eCB) signaling is a key regulator of synaptic neurotransmission and has been implicated in the mechanisms of epilepsy as well as sever...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.12302

    authors: Ma L,Wang L,Yang F,Meng XD,Wu C,Ma H,Jiang W

    更新日期:2014-10-01 00:00:00

  • Post-traumatic stress disorder in Canada.

    abstract::Post-traumatic stress disorder (PTSD) has become a global health issue, with prevalence rates ranging from 1.3% to 37.4%. As there is little current data on PTSD in Canada, an epidemiological study was conducted examining PTSD and related comorbid conditions. Modified versions of the Composite International Diagnostic...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/j.1755-5949.2008.00049.x

    authors: Van Ameringen M,Mancini C,Patterson B,Boyle MH

    更新日期:2008-10-01 00:00:00

  • Clinical Impact of Not Achieving Recommended Dose on Duration of Atomoxetine Treatment in Adults with Attention-Deficit/Hyperactivity Disorder.

    abstract:AIM:To compare atomoxetine (ATX) length of therapy (LoT) among adults with ADHD who reached the recommended dose of 80 mg/day (ATX ≥ 80) versus those who did not (ATX < 80) analyzed separately in patients prescribed ATX as monotherapy (mono) and in combination with other ADHD medications (combo). METHODS:This was a re...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.12595

    authors: Clemow DB,Nyhuis AW,Robinson RL

    更新日期:2016-12-01 00:00:00

  • Vagomimetic effects of fingolimod: physiology and clinical implications.

    abstract::Fingolimod is a sphingosine 1-phosphate (S1P) receptor modulator approved to treat relapsing-remitting multiple sclerosis (MS). Initiation of treatment with fingolimod has been found to produce transient bradycardia and/or slowing of atrioventricular impulse conduction in a small proportion of patients. This effect is...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/cns.12283

    authors: Vanoli E,Pentimalli F,Botto G

    更新日期:2014-06-01 00:00:00

  • Adenosine-dopamine interactions in the pathophysiology and treatment of CNS disorders.

    abstract::Adenosine-dopamine interactions in the central nervous system (CNS) have been studied for many years in view of their relevance for disorders of the CNS and their treatments. The discovery of adenosine and dopamine receptor containing receptor mosaics (RM, higher-order receptor heteromers) in the striatum opened up a ...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1755-5949.2009.00126.x

    authors: Fuxe K,Marcellino D,Borroto-Escuela DO,Guescini M,Fernández-Dueñas V,Tanganelli S,Rivera A,Ciruela F,Agnati LF

    更新日期:2010-06-01 00:00:00

  • Neurovascular Unit: A critical role in ischemic stroke.

    abstract::Ischemic stroke (IS), a common cerebrovascular disease, results from a sudden blockage of a blood vessel in the brain, thereby restricting blood supply to the area in question, and making a significantly negative impact on human health. Unfortunately, current treatments, that are mainly based on a recanalization of oc...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.13561

    authors: Wang L,Xiong X,Zhang L,Shen J

    更新日期:2021-01-02 00:00:00

  • The use of antidepressants for headache prophylaxis.

    abstract::The focus of this review is on the efficacy of antidepressants as preventive treatments for migraine and chronic tension-type headache (TTH). Pharmacologic prophylaxis may be indicated for patients with frequent headaches, who respond insufficiently to acute therapies, or for whom medication overuse is a concern. The ...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1755-5949.2010.00170.x

    authors: Smitherman TA,Walters AB,Maizels M,Penzien DB

    更新日期:2011-10-01 00:00:00

  • Ginsenosides and their CNS targets.

    abstract::Ginsenosides are a special group of triterpenoid saponins attributed to medical effects of ginseng. Therefore, they have been research targets over the last three decades to explain ginseng actions and a wealth of literature has been presented reporting on ginsenosides' effects on the human body. Recently, there is in...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1755-5949.2010.00208.x

    authors: Radad K,Moldzio R,Rausch WD

    更新日期:2011-12-01 00:00:00

  • High salt intake and stroke: meta-analysis of the epidemiologic evidence.

    abstract::Research on the potential impact of high salt intake on health has grown rapidly over the last decades. Recent studies have suggested that high salt intake could also be associated with adverse effects on cardiovascular system. The review evaluated the current level of epidemiologic evidence on the association between...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,meta分析,评审

    doi:10.1111/j.1755-5949.2012.00355.x

    authors: Li XY,Cai XL,Bian PD,Hu LR

    更新日期:2012-08-01 00:00:00

  • Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder.

    abstract::Central dopaminergic and noradrenergic systems play essential roles in controlling several forebrain functions. Consequently, perturbations of these neurotransmissions may contribute to the pathophysiology of neuropsychiatric disorders. For many years, there was a focus on the serotonin (5-HT) system because of the ef...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1755-5949.2010.00146.x

    authors: El Mansari M,Guiard BP,Chernoloz O,Ghanbari R,Katz N,Blier P

    更新日期:2010-06-01 00:00:00

  • Hallucinations in neurodegenerative diseases.

    abstract::Patients with neurodegenerative disease frequently experience hallucinations and illusionary perceptions. As early symptoms, hallucinations may even have diagnostic relevance (i.e., for the diagnosis of Lewy Body Dementia). In the later course of the disease, hallucinations may appear as characteristic symptoms and of...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1755-5949.2011.00247.x

    authors: Burghaus L,Eggers C,Timmermann L,Fink GR,Diederich NJ

    更新日期:2012-02-01 00:00:00

  • B3GNT5 is a novel marker correlated with stem-like phenotype and poor clinical outcome in human gliomas.

    abstract:AIMS:Glioblastoma multiforme (GBM) is the most lethal tumor with a median patient survival of 14 to 15 months. Glioma stem cells (GSCs) play a critical role in tumor initiation and therapeutic resistance in GBM. B3GNT5 has been suggested as the key glycosyltransferase in the biosynthesis of the (neo-) lacto series of g...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.13439

    authors: Jeong HY,Park SY,Kim HJ,Moon S,Lee S,Lee SH,Kim SH

    更新日期:2020-11-01 00:00:00

  • Lives in isolation: stories and struggles of low-income African American women with panic disorder.

    abstract::Research evidence points to the existence of racial-ethnic disparities in both access to and quality of mental health services for African Americans with panic disorder. Current panic disorder evaluation and treatment paradigms are not responsive to the needs of many African Americans. The primary individual, social, ...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/j.1755-5949.2009.00079.x

    authors: Johnson M,Mills TL,Deleon JM,Hartzema AG,Haddad J

    更新日期:2009-10-01 00:00:00

  • Administration of MS-275 improves cognitive performance and reduces cell death following traumatic brain injury in rats.

    abstract:AIMS:The MS-275 is a selective inhibitor of class I histone deacetylases (HDACs), which has been reported as a potential strategy in some central nervous system diseases associated with neurodegeneration and disturbed learning. However, its role in traumatic brain injury is not well defined. In this study, we examined ...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,收录出版

    doi:10.1111/cns.12082

    authors: Cao P,Liang Y,Gao X,Zhao MG,Liang GB

    更新日期:2013-05-01 00:00:00

  • Therapeutic role of 5-HT1A receptors in the treatment of schizophrenia and Parkinson's disease.

    abstract::5-HT(1A) receptors have long been implicated in the pathogenesis and treatment of anxiety and depressive disorders. Recently, several lines of studies have revealed new insights into the therapeutic role of 5-HT(1A) receptors in treating schizophrenia and Parkinson's disease. Specifically, 5-HT(1A) receptors seem to b...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1755-5949.2010.00211.x

    authors: Ohno Y

    更新日期:2011-02-01 00:00:00

  • Sigma-1 receptor knockout impairs neurogenesis in dentate gyrus of adult hippocampus via down-regulation of NMDA receptors.

    abstract:AIMS:This study investigated the influence of sigma-1 receptor (σ1 R) deficiency on adult neurogenesis. METHODS:We employed 8-week-old male σ1 R knockout (σ1 R(-/-) ) mice to examine the proliferation and differentiation of progenitor cells, and the survival and neurite growth of newborn neurons in hippocampal dentate...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.12129

    authors: Sha S,Qu WJ,Li L,Lu ZH,Chen L,Yu WF,Chen L

    更新日期:2013-09-01 00:00:00

  • Morphological and Functional Attenuation of Degeneration of Peripheral Neurons by Mesenchymal Stem Cell-Conditioned Medium in Spinocerebellar Ataxia Type 1-Knock-in Mice.

    abstract:AIMS:Spinocerebellar ataxia type 1 (SCA1) is caused by the ataxin-1 protein (ATXN1) with an abnormally expanded polyglutamine tract and is characterized by progressive neurodegeneration. We previously showed that intrathecal injection of mesenchymal stem cells (MSCs) during the nonsymptomatic stage mitigates the degene...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.12560

    authors: Suto N,Mieda T,Iizuka A,Nakamura K,Hirai H

    更新日期:2016-08-01 00:00:00

  • Tolerance to the prophylactic effects of carbamazepine and related mood stabilizers in the treatment of bipolar disorders.

    abstract::Tolerance development after successful long-term treatment of bipolar disorder is under recognized, as are ways to prevent or show its occurrence or reverse it once it has occurred. We review the clinical literature which suggests that tolerance can develop to most treatment approaches in bipolar illness and present a...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1755-5949.2010.00215.x

    authors: Post RM,Weiss SR

    更新日期:2011-12-01 00:00:00

  • Rosiglitazone polarizes microglia and protects against pilocarpine-induced status epilepticus.

    abstract:AIMS:Activated microglia have been found in the forebrains and hippocampi of temporal lobe epilepsy (TLE) patients and status epileptic (SE) animal models. The peroxisome proliferator-activated receptor γ (PPAR γ) agonist rosiglitazone has been shown to prevent microglial activation. However, its role in pilocarpine-in...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.13265

    authors: Peng J,Wang K,Xiang W,Li Y,Hao Y,Guan Y

    更新日期:2019-12-01 00:00:00

  • Endothelial glycocalyx as an important factor in composition of blood-brain barrier.

    abstract::The blood-brain barrier is a dynamic and complex neurovascular unit that protects neurons from somatic circulatory factors as well as regulates the internal environmental stability of the central nervous system. Endothelial glycocalyx is a critical component of an extended neurovascular unit that influences the struct...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.13560

    authors: Zhao F,Zhong L,Luo Y

    更新日期:2020-12-30 00:00:00

  • Immunogenicity and predictors of response to a single dose trivalent seasonal influenza vaccine in multiple sclerosis patients receiving disease-modifying therapies.

    abstract:AIMS:To evaluate the immunogenicity and safety of a seasonal influenza vaccine in a cohort of multiple sclerosis (MS) patients receiving different immunomodulating/immunosuppressive therapies and assess predictors of immune response. METHODS:A prospective, multicenter, non-randomized observational study including 108 ...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,多中心研究

    doi:10.1111/cns.13034

    authors: Metze C,Winkelmann A,Loebermann M,Hecker M,Schweiger B,Reisinger EC,Zettl UK

    更新日期:2019-02-01 00:00:00

  • Patient diaries as a clinical endpoint in Parkinson's disease clinical trials.

    abstract::Parkinson's disease (PD) is the second most common neurodegenerative disorder with an estimated 4 million patients worldwide. L-dopa is standard, and often initial, therapy for patients with this condition; however, with continued dopaminergic treatment and as the disease progresses, the majority of patients experienc...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1755-5949.2011.00253.x

    authors: Papapetropoulos SS

    更新日期:2012-05-01 00:00:00